Since the arrival of drug-eluting (called drug-eluding by some) technology a few years ago with the promise of reducing restenosis, questions abound surrounding the future of the stent market: After numerous clinical studies and mixed cost-effectiveness results, how is drug-eluding technology expected to peform in the future? What can companies do to best market this technology in the healthcare system of the US and 6 other major world markets? What are the market trends to watch that will determine growth in this field in the coming years? What companies have already established a leadership position in stents and what do start ups have to do to join them? Major World Markets for Stents and The Economics of Drug Eluding Technology, written by Kalorama Analyst Dr. Kenneth Krul, takes a hard look at these questions with economic analysis unmatched by any resource. The field of drug-eluting stents remains an exciting technological innovation that will be a major part of cardiovascular intervention technologies over the next ten years. This report provides a complete market assessment for coronary stents broadly, with emphasis on the economics of drug-eluting stents. Markets sizes and forecasts are divided in two product segments:
As a world market analysis, the report covers markets in the following countries:
This report considers the options that the current technologies present, the progress that is being made in these fields, and the reception these new products are likely to experience in the marketplace. In its brief lifetime (BMSs having only emerged fully in the mid-1990s), the field of coronary stents has shown that it can hold many surprises. Among the information in this complete survey of the coronary stent market, the report contains:
The analysis presented in this report is based on data from a combination of company, government, industrial, institutional and private sources. It includes information from extensive literature reviews, as well as interviews and discussions with experts in the field, including experts in cardiology and cardiac surgery, as well as pathologists, public health experts, research scientists, and business development and marketing managers engaged in the field. Related Reports: Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing IndustryJun 1, 2009 - KLI2155319 - $3,995.00 World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers) May 1, 2009 - KLI1829596 - $3,500.00 Worldwide Wound Care: Total Market Coverage (Vols. I-III: Skin Ulcers, Burns, Surgical and Trauma Wounds), 4th Edition May 1, 2009 - KLI2123150 - $4,995.00 Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition May 1, 2009 - KLI2091313 - $3,995.00 The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition May 1, 2009 - KLI2218043 - $3,995.00 World Market for Dialysis Equipment and Services Apr 1, 2009 - KLI2041112 - $3,500.00 Pharmaceutical Markets in India Apr 1, 2009 - KLI2155338 - $1,295.00 World Markets for Point of Care Diagnostics 2009-13 Apr 1, 2009 - KLI2158347 - $3,300.00 Clinical Nutrition Products: World Markets, 3rd Edition Feb 1, 2009 - KLI2089645 - $3,795.00 The World Market for Gastrointestinal Endoscopy Equipment Jan 1, 2009 - KLI1646595 - $3,500.00 |
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition
Clinical Nutrition Products: World Market, 2nd. Edition
Clinical Nutrition Products: World Markets, 3rd Edition
Vaccines: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
Prescription Dermatological Drugs: Worldwide Market, 6th Edition
|
|||||||||
|
Privacy Policy
|
Terms and Conditions
|
Site Map
|
Return Policy
|
Press
|
Help FAQs
|